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Abstract Text:
INTRODUCTION: Melanoma is the most lethal skin cancer, having a rapid increase over the past
30 years1. The 5-year survival rate after early diagnosis is 99%, while the prognosis for patients
with distant metastasis is particularly poor and the survival rate decreases to a dismal 20%2. To
date, the most effective treatment for melanoma is the early diagnosis, which is followed by
surgical resection3. Therefore, in order to improve these disappointing statistical figures, it is
essential to develop efficient diagnostic tools for rapid detection of disease biomarkers. Minimally
invasive microneedles are promising candidates, as they enable rapid and pain-free biomarker
detection in situ. However, validating the developed microneedle systems is still challenging. To
date, the most commonly used systems for microneedle validation are animal skin models,
commercially available skin models and cell culture supernatants (from 2D cultures)4, 5. Animals
and commercially available skin models can be informative, however their properties such as
stiffness, elasticity, porosity, which vary between different patients, for different skin
types/complexities and for different ages, cannot be easily tailored6, 7. Furthermore, there are
limitations when evaluating skin microneedles in supernatants from 2D cell cultures due to the low
concentration of the biomarkers which are diluted in the cell culture medium. Additionally, spatial
detection is impossible8. Consequently, it is of great importance to develop physiologically relevant
and versatile models for microneedle validation in vitro, that can recapitulate and tune important
features of the skin tissue such as stiffness, structure, porosity and pore interconnectivity, elasticity
and extracellular matrix composition. Biomaterial based scaffolds are a promising approach to
robustly control and tune the above skin tissue futures, and therefore, have great potential as
screening tools for novel biomarker detection techniques 9-11.
The aim of this work was to validate the S100 detection, a marker that is upregulated in
melanoma, on a microporous polymer based 3D melanoma model using a novel
immunodiagnostic microneedle device.
METHODS:3D polymer (PU) based microporous scaffolds (5x5x2.5mm3) were developed as
previously described11 and the metastatic melanoma cell line A-375 was injected and cultured in
those scaffolds for 5 weeks. Quantitative assessment of cell viability took place with the MTS
metabolic assay and evaluation of cell distribution within the PU matrix was conducted with
Scanning Electron Microscopy (SEM). Viable (live) cells were visualised in situ with confocal laser
scanning microscopy (CLSM) of several sections of each scaffold. Furthermore, the detection of
the S100 marker was carried out with PLA microneedles. The PLA microneedle device was
produced, surface modified and coated with the S100 antibody as previously described, followed
by the detection of the antigen via immunoassay analysis on the microneedle surface 12.
RESULTS:The 3D microporous scaffolds were able to support long term growth of the A-375 cells,
with the majority of them being viable until the culture endpoint. Dense melanoma cell masses
adhered to the scaffold pores and were distributed throughout the 3D matrix. Additionally spatial
S100 detection was achieved via immunodiagnostic microneedle administration on the surface of
the 3D scaffolds. The intense signal detection profile revealed that the antigen capture was highly
specific, indicating the ability of the 3D polymeric model to validate the microneedle array.
DISCUSSION & CONCLUSIONS: Our findings indicate that this 3D polymer based microporous
system is a promising tool for ex vivo modelling of metastatic melanoma. The scaffold properties
such as porosity, stiffness and elasticity can be easily controlled and tuned, making this scaffolding
system a promising candidate for modelling different types of skin (e.g. aged skin). Furthermore, to
our knowledge, this is the first time that a 3D in vitro melanoma model is used for validation of
biomarker detection with microneedles. Our findings suggest that this 3D microporous melanoma
scaffold can be used as a low cost tool for validation/screening of novel cancer detection methods
and/or kits, replacing and/or reducing animal testing.
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